What to watch with CYP1A2 and weight loss?

CYP1A2 is the primary enzyme metabolizing caffeine. In weight loss contexts, caffeine is often used to boost thermogenesis and suppress appetite. The rs762551 variant (CYP1A2*1F) classifies individuals as fast (AA) or slow (C-allele) metabolizers. Slow metabolizers may experience prolonged caffeine exposure, increasing risks of sleep disruption, elevated cortisol, and cardiovascular strain – all counterproductive for weight loss. Some studies suggest slow metabolizers have a higher risk of hypertension with high coffee intake, and may not benefit from caffeine's ergogenic effects. However, direct evidence linking CYP1A2 genotype to weight loss success is limited and mostly mechanistic or from observational studies. A DNA test can guide personalized caffeine timing and dosage, but it is not a weight loss predictor. Safety note: Slow metabolizers should limit caffeine to 1–2 cups daily and avoid late consumption to protect sleep quality and stress regulation.